Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011 Scenario, Actual [Member]	Dec. 31, 2010 Scenario, Actual [Member]
Operating Activities
Net Income	$ 15,165	$ 13,509	$ 15,194
Adjustments to reconcile net income to net cash flows provided by operating activities:
Change in deferred acquisition costs	(3,692)	3,908	(4,201)
Depreciation and amortization	8,886	8,029	4,628
Deferred income tax expense	4,252	1,721	4,337
Net realized investment (gains) losses	(3)	(4,193)	(650)
Loss on sale of subsidiary	0	477	0
Stock-based compensation expense	1,044	763	176
Direct stock awards to employees	49	0	0
Amortization of premiums and accretions of discounts on investments	1,283	609	348
Non-controlling interests	72	(170)	(772)
Change in allowance for doubtful accounts	(90)	(31)	(30)
Changes in operating assets and liabilities, net of the effects of acquisitions and dispositions:
Accrued investment income	(306)	(16)	30
Accounts and premiums receivable, net	(4,933)	(898)	3,808
Other receivables	(4,139)	(1,769)	1,884
Reinsurance receivables	(9,248)	(5,181)	4,416
Income Taxes Receivable	(3,628)	818	(818)
Other assets	865	(389)	(1,600)
Unpaid claims	248	(315)	(3,459)
Unearned premiums	7,971	14,373	(5,222)
Policyholder account balances	(2,017)	(45)	0
Accrued expenses, accounts payable and other liabilities	20,190	(14,909)	(7,379)
Income Taxes Payable	(1,344)	1,344	(769)
Deferred revenue	1,363	(6,469)	3,181
Net cash flows provided by (used in) operating activities	31,988	11,166	13,102
Investing Activities:
Proceeds from maturities, calls and prepayments of available-for-sale investments	11,138	9,691	12,114
Proceeds from sales of available-for-sale investments	8,364	62,300	8,769
Net change in short-term investments	100	100	50
Purchases of available-for-sale investments	(40,445)	(62,147)	(24,047)
Purchases of property and equipment	(5,830)	(6,280)	(9,191)
Net paid for acquisitions of subsidiaries, net of cash received	(21,820)	(49,873)	(20,548)
Sale of subsidiary, net of cash paid	0	(153)	0
Proceeds from notes receivable	(1,346)	(975)	684
Change in restricted cash, net of restricted cash received from acquisitions	(9,452)	1,542	2,368
Net cash flows (used in) provided by investing activities	(59,291)	(45,795)	(29,801)
Financing activities
Repayments of notes payable	(130,450)	(74,263)	(20,000)
Proceeds from notes payable	146,888	110,550	25,226
Capitalized closing costs for notes payable	(1,692)	0	(1,379)
Proceeds from Issuance Initial Public Offering	0	0	40,703
Payments for intial public offering costs	0	(826)	0
Payments on redeemable preferred stock	0	(11,040)	(500)
Stockholder funds disbursed at purchase	0	0	(14,105)
Net proceeds from exercise of stock options	20	607	117
Excess tax benefits from stock-based compensation	0	45	86
Purchase of treasury stock	(3,923)	(2,552)	0
Net proceeds received from stock issued in the Employee Stock Purchase Plan	330	58	0
Net cash flows (used in) provided by financing activities	11,173	22,579	30,148
Net (decrease) increase in cash and cash equivalents	(16,130)	(12,050)	13,449
Cash and cash equivalents, beginning of period	31,339	43,389	29,940
Supplemental disclosures of cash payments for:
Interest	5,292	6,184	7,246
Income taxes	8,684	3,451	5,316
Non-cash investing activities
Non-cash consideration received from the sales of subsidiary	$ 0	$ 1,143	$ 0